Nektar Therapeutics (NKTR)
38.95
-0.23
(-0.59%)
USD |
NASDAQ |
Oct 30, 11:13
Nektar Therapeutics Cash and Short Term Investments (Annual) : 245.75M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 245.75M |
| December 31, 2024 | 255.23M |
| December 31, 2023 | 303.62M |
| December 31, 2022 | 504.98M |
| December 31, 2021 | 733.96M |
| December 31, 2020 | 1.062B |
| December 31, 2019 | 1.325B |
| December 31, 2018 | 1.335B |
| December 31, 2017 | 296.13M |
| December 31, 2016 | 389.10M |
| December 31, 2015 | 308.94M |
| December 31, 2014 | 262.82M |
| December 31, 2013 | 237.03M |
| December 31, 2012 | 277.19M |
| December 31, 2011 | 241.17M |
| December 31, 2010 | 315.93M |
| Date | Value |
|---|---|
| December 31, 2009 | 396.21M |
| December 31, 2008 | 378.99M |
| December 31, 2007 | 482.35M |
| December 31, 2006 | 458.64M |
| December 31, 2005 | 476.20M |
| December 31, 2004 | 418.74M |
| December 31, 2003 | 285.97M |
| December 31, 2002 | 293.97M |
| December 31, 2001 | 344.36M |
| December 31, 2000 | 484.84M |
| December 31, 1999 | 138.18M |
| December 31, 1998 | 82.86M |
| December 31, 1997 | 100.17M |
| December 31, 1996 | 36.31M |
| December 31, 1995 | 19.93M |
| December 31, 1994 | 14.42M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Eli Lilly & Co. | 7.268B |
| Inovio Pharmaceuticals, Inc. | 58.51M |
| Tonix Pharmaceuticals Holding Corp. | 207.64M |
| Capricor Therapeutics, Inc. | 318.13M |
| Kyntra Bio, Inc. | 88.98M |